The second installment in Cheddar's Series "The Crypto Craze." Anchors Baker Machado and Tim Stenovec look back at the week in cryptocurrency, and speak with players and experts in this field.
This week, Bitcoin surpassed $17,000 for a short time on Coindesk, and traded around $15,000 on Friday. Litecoin hit a milestone, surpassing $70. But on some exchanges, prices for Bitcoin varied, confusing investors. The Coinbase exchange also took a hit after experiencing record high traffic.
Ryan Surber, Founder of "The Pearly Pig," and contributor for Seeking Alpha, says he could see Bitcoin reaching $90,000 in the near to mid-term. Daniel Roberts, Senior Writer at Yahoo Finance, says that notion is feasible.
We also spoke to an early Bitcoin investor, Jalak Jobanputra, Founder and Managing Partner of Future\Perfect Ventures, who focuses on start-ups in cryptocurrency and blockchain technology. Jobanputra explains the opportunity she sees for Blockchain to disrupt industry.
Danny Taing, founder and CEO of Bokksu, joined Cheddar News to discuss his path on how he became an entrepreneur to launch a company that delivers artisanal Japanese snacks. "When I moved back from Japan to New York, I had this bit of reverse culture shock ... a lot of people had somewhat of a one-dimensional view of Japan ... they saw this country where people ate sushi every day ... none of that is true," he said.
Will Rhind, CEO of GraniteShares, joined Cheddar News to discuss Thursday's trading session amid renewed fears over the regional banking crisis as well as concerns over the debt ceiling debate.
The United Food and Commercial Workers union, one of the country's largest, opposed the planned merger between grocery chains Kroger and Albertson's, according to The Wall Street Journal, citing concerns about lack of information and the potential viability of stores upon closing.
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
